Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$4.18 - $5.48 $10,450 - $13,700
-2,500 Reduced 16.22%
12,917 $62,000
Q4 2023

Jan 29, 2024

SELL
$4.45 - $5.47 $890 - $1,094
-200 Reduced 1.28%
15,417 $78,000
Q3 2023

Oct 16, 2023

SELL
$4.53 - $5.61 $2,265 - $2,805
-500 Reduced 3.1%
15,617 $83,000
Q2 2023

Jul 18, 2023

BUY
$4.64 - $5.98 $2,088 - $2,691
450 Added 2.87%
16,117 $80,000
Q1 2023

May 04, 2023

BUY
$4.85 - $7.84 $82 - $133
17 Added 0.11%
15,667 $80,000
Q1 2022

May 16, 2022

SELL
$8.0 - $10.06 $1,600 - $2,012
-200 Reduced 1.26%
15,650 $151,000
Q4 2021

Feb 09, 2022

BUY
$8.0 - $9.74 $126,800 - $154,379
15,850 New
15,850 $127,000

Others Institutions Holding ICCC

About IMMUCELL CORP


  • Ticker ICCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,746,860
  • Market Cap $28.7M
  • Description
  • ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...
More about ICCC
Track This Portfolio

Track Wealth Effects LLC Portfolio

Follow Wealth Effects LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Effects LLC with notifications on news.